DUB to the rescue.

Mol Cell

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

Published: April 2022

Henning et al. (2022) report development of a novel class of agents, bivalent deubiquitinase (DUB)-targeting chimeras (DUBTACs), that can selectively stabilize protein targets. These findings encourage further pursuit of targeted protein stabilization as a new paradigm in chemical biology and drug discovery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2022.03.039DOI Listing

Publication Analysis

Top Keywords

dub rescue
4
rescue henning
4
henning et al
4
et al 2022
4
2022 report
4
report development
4
development novel
4
novel class
4
class agents
4
agents bivalent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!